Larimar Therapeutics, Inc. (LRMR)
NASDAQ: LRMR · Real-Time Price · USD
3.050
-0.150 (-4.69%)
At close: Jun 30, 2026, 4:00 PM EDT
3.004
-0.046 (-1.50%)
After-hours: Jun 30, 2026, 7:49 PM EDT
Larimar Therapeutics Market Cap
Larimar Therapeutics has a market cap or net worth of $318.37 million as of June 30, 2026. Its market cap has increased by 72.65% in one year.
Market Cap
318.37M
Enterprise Value
121.76M
1-Year Change
72.65%
Ranking
Category
Stock Price
$3.05
Market Cap Chart
Since May 29, 2020, Larimar Therapeutics's market cap has increased from $113.38M to $318.37M, an increase of 180.79%. That is a compound annual growth rate of 18.47%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 30, 2026 | 318.37M | -2.37% |
| Dec 31, 2025 | 326.10M | 32.06% |
| Dec 31, 2024 | 246.93M | 23.61% |
| Dec 29, 2023 | 199.77M | 11.79% |
| Dec 30, 2022 | 178.70M | -6.49% |
| Dec 31, 2021 | 191.10M | -41.88% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| May 29, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Indaptus Therapeutics | 346.52M |
| Greenwich LifeSciences | 341.27M |
| Lineage Cell Therapeutics | 336.55M |
| InflaRx | 335.83M |
| Verastem | 335.68M |
| Opus Genetics | 330.47M |
| Inhibikase Therapeutics | 328.92M |
| Zentalis Pharmaceuticals | 328.17M |